Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder

NCT01663974 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01663974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01663974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
April 30, 2013
Completion date
December 31, 2013
Enrollment
125 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, sub-syndromal symptoms